Physician knowledge of the diagnosis and management of Rocky Mountain spotted fever: Mississippi, 2002

Annals of the New York Academy of Sciences

Volumn 990, Issue , 2003, Pages 295-301

  O'Reilly, M ^a   Paddock, C ^a   Elchos, B ^b   Goddard, J ^d   Childs, James ^a,c   Currie, M ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MISSISSIPPI STATE DEPARTMENT OF HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NONE

Author keywords

Mississippi; Pediatric medicine; Rocky Mountain spotted fever

Indexed keywords

CHLORAMPHENICOL; DOXYCYCLINE;

ANTIBIOTIC THERAPY; CHI SQUARE DISTRIBUTION; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; EARLY DIAGNOSIS; FATALITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; PHYSICIAN; PUBLIC HEALTH SERVICE; ROCKY MOUNTAIN SPOTTED FEVER; SYMPTOM; TICK BORNE DISEASE; UNITED STATES;

ACARI; RICKETTSIALES;

EID: 0038052659     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07379.x     Document Type: Conference Paper

References (13)

1. TREADWELL, T.A., R.C. HOLMAN, M.J. CLARKE, et al. 2000. Rocky Mountain spotted fever in the United States, 1993-1996. Am. J. Trop. Med. Hyg. 63(1,2): 21-26.
2. HELMICK, C.G., K.W. BERNARD & L.J. D'ANGELO. 1984. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J. Infect. Dis. 150(4): 480-488.
3. HATTWICK, M.A., H. RETAILLIAU, R.J. O'BRIEN, et al. 1978. Fatal Rocky Mountain spotted fever. JAMA 240: 1499-1503.
4. PURVIS, J.J. & M.S. EDWARDS. 2000. Doxycycline use for rickettsial disease in pediatric patients. Pediatr. Infect. Dis. J. 19: 871-874.
5. HOLMAN, R.C., C.D. PADDOCK, A.T. CURNS, et al. 2001. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J. Infect. Dis. 184: 1437-1444.
6. BURGDORFER, W., T.R. ADKINS & L.E. PRIESTER. 1975. Rocky Mountain spotted fever (tick-borne-typhus) in South Carolina: an educational program and tick/rickettsial survey in 1973 and 1974. Am. J. Trop. Med. Hyg. 24(5): 866-872.
7. PADDOCK, C.D., P.W. GREER, T.L. FEREBEE, et al. 1999. Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fata, serologically unconfirmed disease. J. Infect. Dis. 179: 1469-1476.
8. EPPES, S.C., J.D. KLEIN, G.M. CAPUTO & C.D. ROSE. 1994. Physician beliefs, attitudes, and approaches toward Lyme disease in an endemic area. Clin. Pediatr. 33: 130-134.
9. ZISKA, M.H., S.T. DONTA & F.C. DEMAREST. 1996. Physician preferences in the diagnosis and treatment of Lyme disease in the United States. Infection 24: 82-86.
10. MAGRI, J.M., M.T. JOHNSON, T.A. HERRING, et al. 2002. Lyme disease knowledge, beliefs and practices of New Hampshire primary care physicians. J. Am. Board Fam. Pract. 15(4): 277-284.
11. CENTERS FOR DISEASE CONTROL AND PREVENTION. 2000. Consequences of Delayed Diagnosis of Rocky Mountain Spotted Fever in Children - West Virginia, Michigan, Tennessee, and Oklahoma, May-July 2000. MMWR 49(39): 885-888.
12. NADELMAN, R.B., J. NOWAKOWSKI, D. FISH, et al. 2001. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes Scapularis tick bite. N. Engl. J. Med. 345: 79-84.
13. KENYON, R.H., R.G. WILLIAMS, C.N. OSTER & C.E. PEDERSEN, 1978. Prophylactic treatment of Rocky Mountain spotted fever. J. Clin. Microbiol. 8: 102-104.